Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Fatigue, Migraine
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021657396
Write-up: Migraine; Fatigue; This is a spontaneous report from a contactable consumer received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202106050931181990-YD44X, Safety Report Unique Identifier GB-MHRA-ADR 25425336. A 29-year-old female patient received BNT162B2, dose 1 via an unspecified route of administration on 02Jun2021 (Batch/Lot number: Unknown), as 1st dose, single for COVID-19 immunization. The patient medical history was not reported. No health concerns, patient has not had symptoms associated with COVID-19, not had a COVID-19 test, patient is not enrolled in clinical trial, patient is not currently breastfeeding. The patient''s concomitant medications were not reported. On 03Jun2021, the patient experienced fatigue and on 04Jun2021 she experienced migraine. Patient has not tested positive for COVID-19 since having the vaccine. The case is serious (medically significant). The outcome of the event fatigue and migraine was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166